TrianglePUBLICATIONS · 28950372
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2017 Dec 1
- First author
- Schöffski P
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Ann Oncol. 2019 Feb 1;30(2):344. doi: 10.1093/annonc/mdx823.
- note
- Source null
- related pmid
- 29741569
- relationship
- Erratum in
Authors and identifiers
- name
- Schöffski P
- type
- Author
- name
- Wozniak A
- type
- Author
- name
- Stacchiotti S
- type
- Author
- name
- Rutkowski P
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Lindner LH
- type
- Author
- name
- Strauss SJ
- type
- Author
- name
- Anthoney A
- type
- Author
- name
- Duffaud F
- type
- Author
- name
- Richter S
- type
- Author
- name
- Grünwald V
- type
- Author
- name
- Leahy MG
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Schöffski P
- type
- Author
- name
- Wozniak A
- type
- Author
- name
- Stacchiotti S
- type
- Author
- name
- Rutkowski P
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Lindner LH
- type
- Author
- name
- Strauss SJ
- type
- Author
- name
- Anthoney A
- type
- Author
- name
- Duffaud F
- type
- Author
- name
- Richter S
- type
- Author
- name
- Grünwald V
- type
- Author
- name
- Leahy MG
- type
- Author
- bibliography ids
- nci-bib-16c08ae504aa220838b5b901
- book metadata
- content sha256
- 5cc8fc4ee7fd26de978b3a8aa70b05a70287eea3d2743d478202fc407bb2dacd
- document type
- citation
- dois
- 10.1093/annonc/mdx527
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28950372
- immutable id
- pubmed:28950372@5cc8fc4ee7fd26de978b3a8aa70b05a70287eea3d2743d478202fc407bb2dacd
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 12
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 3000-3008
- volume
- 28
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Ann Oncol. 2019 Feb 1;30(2):344. doi: 10.1093/annonc/mdx823.
- note
- Source null
- related pmid
- 29741569
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 28950372
- provenance
- batch id
- fb25b16edcb1373b70c1
- provider
- NCBI PubMed ESummary
- record sha256
- 1ce8d9b183e13512ae8e11424a758bfd59d3291188137a1d0a51d29981a81e80
- response sha256
- 182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
- retrieved at
- 2026-09-09T23:47:28.490065+00:00
- publication date
- display
- 2017 Dec 1
- precision
- day
- year
- 2017
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Preserved source evidence · Not medical advice